| | | Control group | Glutamine group | Curcumin group | Nesfatin-1 group | |
| Inflammatory process | Minimal | 2 | 33,33% | 2 | 33,33% | 2 | 33,33% | 0 | 0,00% | 0.481 | Mild | 2 | 33,33% | 2 | 33,33% | 0 | 0,00% | 1 | 16,67% | Moderate | 2 | 33,33% | 2 | 33,33% | 4 | 66,67% | 4 | 66,67% | Severe | 0 | 0,00% | 0 | 0,00% | 0 | 0,00% | 1 | 16,67% |
| Granulation tissue form | Minimal | 1 | 16,67% | 2 | 2,00% | 2 | 33,33% | 0 | 0,00% | | Mild | 4 | 66,67% | 3 | 50,00% | 2 | 33,33% | 2 | 33,33% | 0.401 | Moderate | 1 | 16,67% | 1 | 16,67% | 2 | 33,33% | 4 | 66,67% | |
| Fibroblastic activity | Minimal | 1 | 16,67% | 2 | 33,33% | 1 | 16,67% | 0 | 0,00% | 0.242 | Mild | 1 | 16,67% | 3 | 50,00% | 5 | 83,33% | 3 | 50,00% | Moderate | 3 | 50,00% | 1 | 16,67% | 0 | 0,00% | 3 | 50,00% | Severe | 1 | 16,67% | 0 | 0,00% | 0 | 0,00% | 0 | 0,00% |
| Neo. | Absent | 4 | 66,67% | 1 | 16,67% | 3 | 50,00% | 2 | 33,33% | 0.33 | Present | 2 | 33,33% | 5 | 83,33% | 3 | 50,00% | 4 | 66,67% |
|
|